Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
1/9/2024
Chinese Patent Examination Guidelines 2023 – Toby's Observations
1/8/2024
Foreign Drug Giants Shift Strategy on China Sales as Competition Ramps...
1/7/2024
Christmas Present from China – Implementation Regulations of the Chin...
1/7/2024
Why Is TikTok Parent ByteDance Moving into Biology, Chemistry and Drug...
1/7/2024
Chinese Pharmaceutical Companies Chart New Paths in the Middle East (K...
1/6/2024
Balancing Medical Innovation and Affordability in The New Healthcare E...
12/28/2023
China's Revised Measures for the Administration and Registration of Fo...
12/27/2023
Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win (Se...
12/26/2023
2024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
12/20/2023
China NRDL 2023 Readout: the Seven-year Itch (Simon Kucher)
12/15/2023
China Biopharma Tracker – Novermber 2023 (PharmaDJ)
12/14/2023
The Impact of Experimental Data on Support of Disclosure and Inventive...
12/12/2023
Can China's Biotech Industry Weather Frosty US Relations? (PharmaPhoru...
12/6/2023
Asia Toughing Out the Uncertainties and Challenges (BioSpectrum)
12/5/2023
China Biotech: Investors Fear a Negative Reaction from the US (FT)
12/3/2023
Navigating Another New Normal in China as De-risking Starts to Bite Pr...
11/24/2023
China Biopharma: Charting a Path to Value Creation (McKinsey)
11/24/2023
China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
11/23/2023
PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
11/22/2023
Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
11/20/2023
Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
11/16/2023
Riding The Tide, Realize the Future: The BD Paths For Chinese Biotech ...
11/16/2023
Chinese Patent Office Hands Down Key Ruling on Pharma Patent Requireme...
11/15/2023
China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Par...
11/14/2023
NMPA: Quick Review of 2022 Drug Review Annual Report
11/10/2023
China's Strength Is Innovation on Innovation, Western Partners Are Lin...
11/8/2023
The Growing Pains of Chinese Biotech (In Vivo Citeline)
11/6/2023
Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
10/31/2023
Big Questions Face MNC Pharma's China Business as Sustainability of th...
10/31/2023
Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
Page:
3
/
7
Total number of articles:
190
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit